Trending
- Research shows five SBRT sessions are as effective as 39 for radiotherapy in prostate cancer
- BIR/DeepHealth Mayneord Memorial lecture awarded to Professor Rockall
- Cancer alliance uses AI for faster reporting of significant findings on chest x-rays
- Confidence is partnering with AGITO Medical
- Royal Alexandra Children’s Hospital partners with Canon Medical to reduce anxiety over scans
- Vertec adds immobilisation products from Meicen
- Leeds Teaching Hospitals pilots AI tool for prostate cancer diagnosis from MRI
- Bracco brings UK repair and testing in-house
- Scanner centre to investigate whether SAD lamps can lift workforce mood
- Watford General’s resus team is on the fast track
SPECT/CT imaging of bone
Author(s): Dr Zubair Ali Khan, Dr Abdul-Aziz Al-Sugair
Hospital: Western General Hospital, King Faisal Specialist Hospital and Research Centre
Reference: RAD Magazine, 41, 483, 21-23
Excerpt: The skeleton is a metabolically active organ that undergoes continuous remodelling throughout life. Normal healthy bones are dynamic structures with inherent basal levels of turnover sustained by balanced osteoblastic and osteoclastic activity. Increased bone turnover (ie osteoblastic activity) is the central mechanism of attempts at bone healing in case of any insult, whether it is benign or malignant. Radionuclide 99mTc-MDP is a tracer that gets adsorbed into bone in proportion to bone turnover and thus provides an “osteoblastic map” of the entire skeleton. 99mTc-MDP planar bone scintigraphy has historically been employed in regular staging and re-staging of many cancers as well as for answering specific questions in orthopaedics. Many malignancies, eg breast, prostate, lung, thyroid and renal cell carcinomas, have a tendency to metastasize to bone.